Genetics-based medication matching software
Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options
This project builds software that helps doctors use a patient's genetic test to pick and dose medicines more safely and effectively.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Golden Helix, INC. NIH-funded |
| Lab location | 1 site (Bozeman, United States) |
| Project ID | NIH-11063650 on NIH RePORTER |
What this research studies
If you get genetic testing, this project improves a software tool that reads sequencing results and turns them into clear reports about which drugs and doses may work best for you. The team will expand the database of drug–gene information, include FDA labels and clinical risk factors, and make the system scale for larger labs. They will also work to connect the software with electronic health records so your results can appear directly in the doctor’s workflow. Overall, the effort is meant to make pharmacogenomic testing easier for labs and clinicians to use when treating patients.
Who could benefit from this research
Good fit: People who have or plan to have pharmacogenetic testing, those on multiple medications, or patients who have experienced adverse drug reactions would be most relevant for this work.
Not a fit: People without genetic testing data or those whose treatment does not depend on known drug–gene interactions may not receive direct benefit from this software.
Why it matters
Potential benefit: If successful, this could help you and your doctor choose medicines and doses that are more effective and cause fewer side effects.
How similar studies have performed: Pharmacogenomics and clinical decision-support tools have shown benefit for many drug–gene pairs and other software has been used in clinics, but broad, seamless implementation is still emerging.
Where this research is happening
Bozeman, United States
- Golden Helix, INC. — Bozeman, United States (Active)
Researchers
- Principal investigator: Scherer, Andreas — Golden Helix, INC.
- Study coordinator: Scherer, Andreas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.